Author

P. Guan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Binte Mohamed Bashir· 1 shared B. T. Teh· 1 shared B. Wang· 1 shared B. Yusuf· 1 shared B. Zhang· 1 shared C. Fang· 1 shared D. P. McDonnell· 1 shared D. Rhodes· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Binte Mohamed Bashir

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A 10-valent composite mRNA vaccine against both influenza and COVID-19

Y. Wang, Q. Ma, M. Li, Q. Mai, L. Ma, H. Zhang, H. Zhong, N. Cheng, P. Feng, P. Guan, S. Wu, L. Zhang, J. Dai, B. Zhang, W. Pan, Z. Yang

This paper introduces FLUCOV-10, a 10-valent mRNA vaccine targeting influenza and SARS-CoV-2, showing robust immune responses and complete protection in mice against multiple strains.

bioRxiv · Mar 5, 2024 · PreprintMicrobiology

Effects of breast fibroepithelial tumor associated retinoic acid receptor alpha ligand binding domain mutations on receptor function and retinoid signaling

X. X. Huang, L. M. Ng, P.-H. Lee, P. Guan, M. J. Chow, A. Binte Mohamed Bashir, M. Lau, K. Tan, Z. Li, J. Chan, J. Hong, S. R. Ng, H. L. Teo, D. Rhodes, P. Tan, , B. T. Teh

This study examines how mutations in the RAR ligand binding domain affect retinoic acid signaling and tumorigenesis in breast fibroepithelial tumors.

bioRxiv · Dec 1, 2022 · PreprintCancer Biology

A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line tuberculosis regimen

G. Chiwala, Z. Liu, J. N. Mugweru, B. Wang, S. A. Khan, P. N. N. Bate, B. Yusuf, H. M. A. Hameed, C. Fang, Y. Tan, P. Guan, J. Hu, S.-Y. Tan, J. Liu, N. Zhong, T. Zhang

This study develops a drug-resistant recombinant BCG vaccine that enhances second-line TB treatment efficacy in a murine model of drug-resistant tuberculosis.

bioRxiv · Mar 4, 2021Microbiology